Comparing Immunotherapy Costs Between Centres — What to Check in Every Quote

Nine lines, each priced on its own: the exact medicine and dose per cycle, the cycle count the figure covers, day-care administration, pre-cycle bloods, hormone monitoring, response-assessment imaging, review consultations, what a side effect would add, and taxes. Plus a date. Indicative, as of August 2026.

Families are usually handed a single number and asked to decide against it. That number is not a quote — it is a headline. Two centres can produce totals that differ by lakhs while describing exactly the same treatment, simply because one document contains six lines and the other contains one. Use the table below as a common form. Ask each centre to fill it in.

For context on what these lines usually come to across a full course, see Immunotherapy Cost in India: What a Full Course Actually Comes To. At CION, immunotherapy is administered as day care — you come in, are treated, and go home the same day. Response-assessment PET-CT is coordinated at partner imaging centres, not owned by CION, and those scans are billed by the imaging centre directly, so they will never appear on a CION quote at all. Ask every centre you approach who raises that bill.

Mostly because the quotes are built differently, not because one centre charges twice as much for the same thing. The product chosen, the dose basis, the cycle interval assumed, what is bundled into the day-care charge, who bills the imaging, and scheme empanelment all move the total. Indicative, as of August 2026.

• Which product is prescribed. A domestically manufactured version of a molecule and the reference product are priced very differently. One checkpoint inhibitor molecule has had an Indian-made version available since January 2026; for most others no such version exists yet. This is usually the single largest gap between two quotes — see Biosimilars and Generic Entry: How Much Can You Actually Save?
• How the dose is calculated. Some checkpoint inhibitors are dosed by body weight and some at a flat dose. A weight-based drug costs a heavier patient more, and how much of a vial is left unused can differ between centres depending on the vial sizes stocked.
• The cycle interval assumed. The same molecule may be given two-weekly, three-weekly or six-weekly. A total built on a three-weekly schedule and one built on a six-weekly schedule are not describing the same year.
• What the day-care charge covers. At one centre, chair time, nursing and pre-medication sit inside the cycle price. At another, each is billed as its own line. Neither is wrong; only one is visible in the headline number.
• Whether monitoring is bundled. Pre-cycle bloods and thyroid monitoring are inside the package at some centres and billed test by test at others, and these recur for as long as treatment continues.
• Who raises the imaging bill. Response-assessment scans may be done in-house or coordinated at a partner imaging centre and billed by them. Published whole-body PET-CT rates start at ₹9,999 for analog and ₹14,950 for digital, indicative as of August 2026.
• Scheme empanelment. Whether a centre is empanelled for the scheme you hold changes your out-of-pocket amount far more than a difference in sticker price does.
• Room category, if an admission is ever needed. Many hospital charges scale with the room band selected, so the same complication costs differently inside the same hospital.
• Taxes and pharmacy handling. A figure quoted before taxes and handling will not match the bill, and a quote that is silent on this is the one most likely to move.

None of this means the higher quote is padded or the lower one unsafe. It usually means the two documents are answering different questions. Your job is to make them answer the same one.

Force both onto the same basis before you look at the totals. Same molecule and product. Same dose and cycle interval. Same number of cycles, counted to the first response assessment. Same inclusion list. Same tax basis. Then the two numbers finally mean something.

Once both documents describe the same treatment over the same window with the same lines, the difference that remains is a real difference — and it is usually far smaller than the first comparison suggested. Where a genuine gap survives, it is worth asking what sits behind it: a different sourcing route for the medicine, a different monitoring intensity, or simply a centre that has left something out. Local indicative ranges are set out in Immunotherapy Cost in Hyderabad: Indicative Ranges if you want a reference point before you start.

The lowest quote is not automatically the lowest cost. A total that excludes monitoring, scans and side-effect management is a smaller number describing a smaller promise. And if the honest arithmetic says no quote is affordable, that belongs in a conversation with the treating oncologist before the first cycle — not in a decision made silently. Not starting, or starting a different plan, is a legitimate option and a common one.

Seven, asked identically everywhere so the answers can be laid side by side. Put them to the billing or cost-counselling desk rather than the treating doctor, ask them at every centre in the same words, and ask for the answers in writing with a date on them.

1. 1

   “Which exact product will be used, and what does one cycle of it cost?”

   Product, strength and dose per cycle. A molecule name on its own is not enough where more than one approved version is on the market.

2. 2

   “How many cycles does this figure cover, and how many before the first assessment?”

   This converts a vague annual number into a window a family can actually fund and actually verify.

3. 3

   “What is inside the cycle charge, and what is billed separately?”

   Ask for day care, bloods, hormone monitoring, consultations and scans shown as their own lines, not as one package figure.

4. 4

   “Who bills the response scans, and how often are they done?”

   Where imaging is coordinated at a partner centre, those bills come from the imaging centre and never appear on the hospital estimate.

5. 5

   “What would an immune side effect add — as an outpatient, and as an admission?”

   Ask for both versions. The admission version is the one that derails budgets, and it is almost never volunteered.

6. 6

   “Are you empanelled for my scheme, and where does my policy stand?”

   Ask the scheme desk and the insurance desk, not the oncologist. Get the current position dated and in writing before you commit.

7. 7

   “Are these figures inclusive of taxes and pharmacy handling?”

   The cheapest-looking quote is often the one prepared exclusive of both. Ask for the answer written on the estimate itself.

Asking three centres the same seven questions is not disloyalty, and it does not delay care. Cost counselling is a normal part of a cancer pathway in India, and a centre unwilling to answer any of these in writing has told you something useful about how the bill will behave later.

Six. An undated or verbal-only figure. A lump sum with no contents list. Any promise that a scheme or insurer will pay. Any promise about how the treatment will turn out. Pressure to decide the same day. And any suggestion that the medicine be bought outside the hospital pharmacy.

• No date on the document. Drug prices, package contents and scheme ceilings all change. An undated quote cannot be compared with a dated one, and cannot be held to when the bill arrives.
• One lump sum, no contents list. A package figure with no line items cannot be checked against a bill. Ask what is inside it, and ask what happens when you need something that is not.
• A promise that a scheme or insurer will pay. No hospital can commit an insurer or a scheme desk on your behalf. Coverage is decided on your documents and your diagnosis, and it can be refused. Ask for the pre-authorisation position in writing, not a reassurance across a counter.
• A promise about the outcome. Immunotherapy helps a proportion of patients and does not help others, and which group a person falls into is not known in advance. Any centre attaching an outcome to a price is describing something no oncologist can commit to.
• Pressure to start immediately at a price that holds only today. Cancer treatment can be time-sensitive; a discount deadline is not. Discuss urgency with the oncologist, and discuss money separately, with the desk whose job it is.
• Any route that buys the medicine outside the hospital pharmacy. Counterfeit checkpoint inhibitors have been reported entering the Indian supply chain. A cold-chain medicine bought off-bill cannot be traced, verified or returned, and the saving is not worth what is being risked.

Comparing two documents is the first step. Knowing what the numbers inside them usually look like is the second. These three companion pages give you the reference points to judge whether any quote in front of you is in a normal range at all.

• Immunotherapy Cost in India: What a Full Course Actually Comes To — how a full course is built up line by line nationally, so you can sanity-check any single quote against it.
• Immunotherapy Cost in Hyderabad: Indicative Ranges — local indicative ranges, dated, for families comparing centres inside Telangana.
• Biosimilars and Generic Entry: How Much Can You Actually Save? — why the product named on the quote is usually the biggest lever, and what has and has not changed in India.
• Immunotherapy at CION Cancer Clinics — how eligibility review, day-care treatment, monitoring and cost counselling fit together as one pathway.

A Number You Can Check, Not Just Accept

We show the whole bill first, including the lines most estimates leave out, so the decision stays with your family.